Abstract Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) driven by antigen-specific CD4+ T cell mediated destruction of the myelin sheath. Most T cells circulate between lymphoid organs and peripheral tissues, but a fraction can establish tissue residence and do not recirculate. Growing evidence suggests resident T cells exist in the CNS of MS patients, however, their contribution to disease progression and whether they can cause relapses independently of peripheral T cells is unclear. Current disease modifying therapies for MS patients are not curative and none target CNS resident T cells. Using a murine model of MS, Experimental autoimmune encephalomyelitis (EAE), we investigated whether resident T cells form in the CNS of diseased mice and their contribution to disease pathogenesis. Our data show that antigen-specific CNS resident T cells can be detected during EAE by intravital antibody staining and CD69 expression. Following depletion of circulating CD4+ T cells, CNS resident CD69+ CD4+ T cells maintained their numbers, while the number of CD69- T cells in the CNS was significantly depleted. These CNS resident T cells can drive severe disease in the absence of circulating CD4+ T cells and showed memory-like properties including high proliferative capacity and increased cytokine polyfunctionality compared to early effector T cells. Therefore, disruption of resident T cell function in MS patients could represent a novel target for MS therapies.
Read full abstract